PharmaBoardroom

A perspective on Indonesia’s booming market for contraceptive products from Hendra Gunawan, managing director of PT Tunggal Idaman Abdi, one of…

The chairman and CEO of Medigen shares his insights on a significant past three years for the company, which included both an IPO and major…

Dr. Patry holds a B.A.Sc. and M.A.Sc. in civil engineering from the University of Ottawa, and a Ph.D. from the University of California, Davis in…

Why did P&G decide to set up the center in Singapore? There are several reasons why P&G decided on Singapore. First, we wanted to reach more…

Would you outline the commitment of the Ministry to foster a positive business environment for the Australian pharmaceutical industry to prosper?…

You established Menarini’s Irish affiliate in 1999. How have you seen the market evolve over these last 13 years? The major changes in the market…

The Aspen Group identified Latin America as a “large developing market where it can leverage its substantial intellectual property portfolio and…

If we look back at the conditions under which you founded Biocon in 1978, we see a young woman with a seed capital of only Rs. 10,000 in a garage in…

Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully…

¿Porque fue creado en Ministerio de Ciencia y Tecnología, con que visión? Muchos países están aportando importancia a la ciencia y tecnología y…